Activins and follistatins: Emerging roles in liver physiology and cancer
about
Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga.The effects of transforming growth factor-β2 on the expression of follistatin and activin A in normal and glaucomatous human trabecular meshwork cells and tissues.Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report.Activin A and follistatin in patients with nonalcoholic fatty liver disease.Strategies to produce hepatocytes and hepatocyte-like cells from pluripotent stem cells.BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.Midgut-Derived Activin Regulates Glucagon-like Action in the Fat Body and Glycemic Control.Up-Regulation of Follistatin-Like 1 By the Androgen Receptor and Melanoma Antigen-A11 in Prostate Cancer.Magnolol Attenuates Concanavalin A-induced Hepatic Fibrosis, Inhibits CD4+ T Helper 17 (Th17) Cell Differentiation and Suppresses Hepatic Stellate Cell Activation: Blockade of Smad3/Smad4 Signalling.Adenovirus‑mediated knockdown of activin A receptor type 2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells.
P2860
Q35563500-5B3E454A-DA65-4F1A-8265-6B6667609432Q36061236-D58651C9-49AB-44B5-B24C-73CEBAD5F68DQ36366799-00370934-0D1C-4862-971F-193D448331B6Q36566934-D3BAE3F1-6FA8-4C05-8F67-2370A494B512Q37715878-47C97F42-A56A-45B3-84A4-4694D7BC8BFEQ38821923-9D3BB6F6-0977-47B7-B2AE-EB8BDE6ADA2BQ39698876-7F361CBB-465F-40FD-9B65-2A81CFE9D642Q47237512-707DFB3E-DE5B-4B9D-9447-BF4C06971C37Q49727393-00511FF0-534F-47DB-8C2C-E40069884AFBQ51263170-A7110994-3439-4A14-88A0-5110E2D1FFAAQ52935358-215BAC44-B7F4-4547-B18A-198670ECD95AQ55223894-3098833F-49A4-425E-86EF-21EA18C148E7
P2860
Activins and follistatins: Emerging roles in liver physiology and cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activins and follistatins: Emerging roles in liver physiology and cancer
@ast
Activins and follistatins: Emerging roles in liver physiology and cancer
@en
Activins and follistatins: Emerging roles in liver physiology and cancer
@nl
type
label
Activins and follistatins: Emerging roles in liver physiology and cancer
@ast
Activins and follistatins: Emerging roles in liver physiology and cancer
@en
Activins and follistatins: Emerging roles in liver physiology and cancer
@nl
prefLabel
Activins and follistatins: Emerging roles in liver physiology and cancer
@ast
Activins and follistatins: Emerging roles in liver physiology and cancer
@en
Activins and follistatins: Emerging roles in liver physiology and cancer
@nl
P2860
P50
P356
P1476
Activins and follistatins: Emerging roles in liver physiology and cancer
@en
P2093
Deniz Oztürk
Thomas Metzner
P2860
P356
10.4254/WJH.V1.I1.17
P577
2009-10-01T00:00:00Z